Literature DB >> 16871531

Classification criteria for psoriatic arthritis: development of new criteria from a large international study.

William Taylor1, Dafna Gladman, Philip Helliwell, Antonio Marchesoni, Philip Mease, Herman Mielants.   

Abstract

OBJECTIVE: To compare the accuracy of existing classification criteria for the diagnosis of psoriatic arthritis (PsA) and to construct new criteria from observed data.
METHODS: Data were collected prospectively from consecutive clinic attendees with PsA and other inflammatory arthropathies. Subjects were classified by each of 7 criteria. Sensitivity and specificity were compared using conditional logistic regression analysis. Latent class analysis was used to calculate criteria accuracy in order to confirm the validity of clinical diagnosis as the gold standard definition of "case"-ness. Classification and Regression Trees methodology and logistic regression were used to identify items for new criteria, which were then constructed using a receiver operating characteristic curve.
RESULTS: Data were collected on 588 cases and 536 controls with rheumatoid arthritis (n = 384), ankylosing spondylitis (n = 72), undifferentiated arthritis (n = 38), connective tissue disorders (n = 14), and other diseases (n = 28). The specificity of each set of criteria was high. The sensitivity of the Vasey and Espinoza method (0.97) was similar to that of the method of McGonagle et al (0.98) and greater than that of the methods of Bennett (0.44), Moll and Wright (0.91), the European Spondylarthropathy Study Group (0.74), and Gladman et al (0.91). The CASPAR (ClASsification criteria for Psoriatic ARthritis) criteria consisted of established inflammatory articular disease with at least 3 points from the following features: current psoriasis (assigned a score of 2; all other features were assigned a score of 1), a history of psoriasis (unless current psoriasis was present), a family history of psoriasis (unless current psoriasis was present or there was a history of psoriasis), dactylitis, juxtaarticular new bone formation, rheumatoid factor negativity, and nail dystrophy. These criteria were more specific (0.987 versus 0.960) but less sensitive (0.914 versus 0.972) than those of Vasey and Espinoza.
CONCLUSION: The CASPAR criteria are simple and highly specific but less sensitive than the Vasey and Espinoza criteria.

Entities:  

Mesh:

Year:  2006        PMID: 16871531     DOI: 10.1002/art.21972

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  803 in total

1.  Treating psoriatic arthritis to target: discordance between physicians and patients' assessment, non-adherence, and restricted access to drugs precluded therapy escalation in a real-world cohort.

Authors:  Manoela Fantinel Ferreira; Charles Lubianca Kohem; Ricardo Machado Xavier; Everton Abegg; Otavio Silveira Martins; Marcus Barg Resmini; Ariele Lima de Mello; Franciele de Almeida Menegat; Vanessa Hax; Andrese Aline Gasparin; Claiton Viegas Brenol; Nicole Pamplona Bueno de Andrade; Daniela Viecceli; João Carlos Tavares Brenol; Penélope Esther Palominos
Journal:  Clin Rheumatol       Date:  2018-12-03       Impact factor: 2.980

2.  Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study.

Authors:  Luisa Costa; Francesco Caso; Roberta Ramonda; Antonio Del Puente; Luca Cantarini; Md Abud Darda; Paolo Caso; Mariagrazia Lorenzin; Ugo Fiocco; Leonardo Punzi; Raffaele Scarpa
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

3.  Synovial fluid and serum levels of IL-17, IL-23, and CCL-20 in rheumatoid arthritis and psoriatic arthritis: a Tunisian cross-sectional study.

Authors:  Dalila Mrabet; Lilia Laadhar; Héla Sahli; Béchir Zouari; Slim Haouet; Sondès Makni; Slaheddine Sellami
Journal:  Rheumatol Int       Date:  2011-11-16       Impact factor: 2.631

Review 4.  The genetics of psoriasis and psoriatic arthritis.

Authors:  Vinod Chandran
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

5.  [Expectations of rheumatologists on imaging results].

Authors:  C Dejaco; C Duftner; M Schirmer
Journal:  Radiologe       Date:  2012-02       Impact factor: 0.635

6.  Multiple arthritis: three in one.

Authors:  Celia Coelho Henriques; Filipa Lourenço; Begoña Lopéz; António Panarra; Nuno Riso
Journal:  BMJ Case Rep       Date:  2012-03-08

7.  Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study.

Authors:  Floranne C Wilson; Murat Icen; Cynthia S Crowson; Marian T McEvoy; Sherine E Gabriel; Hilal Maradit Kremers
Journal:  Arthritis Rheum       Date:  2009-02-15

8.  Patterns of peripheral joint involvement in psoriatic arthritis-Symmetric, ray and/or row?

Authors:  Vinod Chandran; Lynne Stecher; Vern Farewell; Dafna D Gladman
Journal:  Semin Arthritis Rheum       Date:  2018-03-09       Impact factor: 5.532

9.  Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study.

Authors:  Maddalena Napolitano; Luisa Costa; Francesco Caso; Matteo Megna; Raffaele Scarpa; Nicola Balato; Fabio Ayala; Anna Balato
Journal:  Clin Rheumatol       Date:  2017-05-31       Impact factor: 2.980

10.  [Screening and early diagnosis of psoriasis arthritis].

Authors:  P Härle
Journal:  Z Rheumatol       Date:  2013-10       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.